Structure of Lactoferrin (Wikipedia)
Dutch start-up Vivici has raised an investment of €32.5 million. The company makes dairy proteins using precision fermentation. Their second dairy ingredient will be launched later this year.
Vivici was founded two years ago from a collaboration between Dutch-Swiss ingredient producer DSM-Firmenich and dairy multinational Fonterra. In 2023, the collaboration continued as a start-up with the two large companies as investors. Now three more investors have joined, namely ABP, Invest-NL and InnovationQuarter.
Based on precision fermentation technology, Vivici makes alternative proteins for the food industry and currently especially for popular protein drinks.
With this investment, they will not only further scale up their production but also bring another protein to the market, namely Lactoferrin. This protein is good for the immune system and will be used in baby food, among other things. These alternative proteins are healthy and sustainable.
Stephan van Sint Fiet, CEO of Vivici, sees this investment as an important step for the company: “With this investment, we accelerate our mission to commercialize sustainable proteins from precision fermentation at large scale. With our Vivitein protein platform, we bring a new standard in protein production to the international market, which will become a permanent value in consumer products.”